Swiss National Bank
NVAX icon

Swiss National Bank’s Novavax NVAX Stock Holding History

Swiss National Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Hold
272,100
– – ﹤0.01% 1796
2025
Q4 		$1.83M Sell
272,100
-10,500
-4% -$79.2K ﹤0.01% 1913
2025
Q3 		$2.45M Buy
282,600
+5,900
+2% +$45.9K ﹤0.01% 1753
2025
Q2 		$1.74M Sell
276,700
-2,600
-0.9% -$17.2K ﹤0.01% 1876
2025
Q1 		$1.79M Sell
279,300
-4,100
-1% -$33.9K ﹤0.01% 1834
2024
Q4 		$2.28M Buy
283,400
+35,600
+14% +$343K ﹤0.01% 1774
2024
Q3 		$3.13M Hold
247,800
– – ﹤0.01% 1598
2024
Q2 		$3.14M Buy
247,800
+36,800
+17% +$370K ﹤0.01% 1560
2024
Q1 		$1.01M Buy
211,000
+30,800
+17% +$143K ﹤0.01% 2219
2023
Q4 		$865K Hold
180,200
– – ﹤0.01% 2319
2023
Q3 		$1.3M Sell
180,200
-7,400
-4% -$59.1K ﹤0.01% 2097
2023
Q2 		$1.39M Buy
187,600
+18,100
+11% +$142K ﹤0.01% 2125
2023
Q1 		$1.17M Sell
169,500
-19,400
-10% -$178K ﹤0.01% 2164
2022
Q4 		$1.94M Buy
188,900
+3,600
+2% +$63.5K ﹤0.01% 1914
2022
Q3 		$3.37M Buy
185,300
+5,500
+3% +$238K ﹤0.01% 1525
2022
Q2 		$9.25M Sell
179,800
-131,300
-42% -$6.8M 0.01% 962
2022
Q1 		$22.9M Buy
311,100
+42,100
+16% +$3.75M 0.01% 657
2021
Q4 		$38.5M Sell
269,000
-9,500
-3% -$1.63M 0.02% 550
2021
Q3 		$57.7M Sell
278,500
-7,600
-3% -$1.67M 0.04% 448
2021
Q2 		$60.7M Buy
286,100
+140,700
+97% +$25.8M 0.04% 451
2021
Q1 		$26.4M Buy
145,400
+6,900
+5% +$1.37M 0.02% 623
2020
Q4 		$15.4M Buy
138,500
+7,100
+5% +$755K 0.01% 730
2020
Q3 		$14.2M Buy
131,400
+16,400
+14% +$2M 0.01% 686
2020
Q2 		$9.59M Buy
+115,000
New +$4.4M 0.01% 794
2019
Q4 		– Sell
-43,688
Closed -$219K – 2527
2019
Q3 		$219K Hold
43,688
– – ﹤0.01% 2490
2019
Q2 		$256K Buy
43,688
+8,800
+25% +$69.3K ﹤0.01% 2526
2019
Q1 		$384K Buy
34,888
+1,060
+3% +$33.5K ﹤0.01% 2425
2018
Q4 		$1.25M Buy
33,828
+540
+2% +$20.9K ﹤0.01% 1868
2018
Q3 		$1.25M Buy
33,288
+5,050
+18% +$142K ﹤0.01% 2019
2018
Q2 		$757K Hold
28,238
– – ﹤0.01% 2314
2018
Q1 		$1.19M Buy
28,238
+1,195
+4% +$48K ﹤0.01% 1977
2017
Q4 		$671K Buy
27,043
+4,690
+21% +$114K ﹤0.01% 2315
2017
Q3 		$510K Hold
22,353
– – ﹤0.01% 2377
2017
Q2 		$514K Hold
22,353
– – ﹤0.01% 2400
2017
Q1 		$572K Hold
22,353
– – ﹤0.01% 2326
2016
Q4 		$563K Hold
22,353
– – ﹤0.01% 2339
2016
Q3 		$930K Sell
22,353
-650
-3% -$83.9K ﹤0.01% 2010
2016
Q2 		$3.35M Hold
23,003
– – 0.01% 1143
2016
Q1 		$2.29M Buy
23,003
+5,595
+32% +$600K ﹤0.01% 1361
2015
Q4 		$2.92M Hold
17,408
– – 0.01% 1089
2015
Q3 		$2.46M Buy
17,408
+2,415
+16% +$542K 0.01% 1170
2015
Q2 		$3.34M Buy
14,993
+270
+2% +$47.5K 0.01% 988
2015
Q1 		$2.44M Buy
14,723
+2,015
+16% +$327K 0.01% 1162
2014
Q4 		$1.51M Buy
12,708
+435
+4% +$45.5K 0.01% 1477
2014
Q3 		$1.02M Sell
12,273
-275
-2% -$24.9K ﹤0.01% 1653
2014
Q2 		$1.16M Buy
12,548
+1,550
+14% +$136K ﹤0.01% 1632
2014
Q1 		$996K Buy
10,998
+3,670
+50% +$410K ﹤0.01% 1713
2013
Q4 		$750K Hold
7,328
– – ﹤0.01% 1737
2013
Q3 		$463K Buy
7,328
+1,648
+29% +$92.8K ﹤0.01% 1982
2013
Q2 		$233K Buy
+5,680
New +$246K ﹤0.01% 2314

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's NVAX Position: Q1 2026 in Review

Swiss National Bank held its Novavax (NVAX) position steady in Q1 2026 at 272,100 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Swiss National Bank first reported a position in NVAX in Q2 2013 and has held it in 50 quarters since. The position peaked at $60.7M in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Swiss National Bank held 272,100 shares of Novavax worth $2.21M as of Q1 2026.
  • Swiss National Bank left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1796 holding.
  • Swiss National Bank first reported a position in Novavax in Q2 2013 and has held it in 50 quarters since.
  • Swiss National Bank's Novavax position peaked at $60.7M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.